Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Newron Pharmaceuticals SpA    NWRN   IT0004147952

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Newron Pharmaceuticals SpA
Discovers and develops small molecule drugs

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.

The focus of its treatments includes patients with Parkinson's disease, Rett Syndrome, Amyotrophic Lateral Sclerosis, schizoprenia, and neuropathic pain.

The company was founded by Luca Benatti, Ruggero Fariello, and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Number of employees : 23 persons.
Sales per Businesses
20152016Delta
CHF (in Million)%CHF (in Million)%
Pharmaceutical Drugs1.9279.1%5.16100% +168.6%
Sales per Regions
20152016Delta
CHF (in Million)%CHF (in Million)%
Global1.9279.1%5.16100% +168.6%
Managers
NameAgeSinceTitle
Stefan Weber522005Chief Executive Officer, Director & IR Contact
Ulrich Köstlin, PhD652013Non-Executive Chairman
Roberto Galli-2002Vice President-Finance
Ravi Anand, MD602005Chief Medical Officer
Patrick J. Langlois, PhD722008Independent Non-Executive Director
Robert Leslie Holland MD, PhD622013Independent Non-Executive Director
Bo Jesper Hansen MD, PhD592013Independent Non-Executive Director
Joseph Donald deBethizy, PhD662014Independent Non-Executive Director
Luca Benatti, PhD562014Independent Non-Executive Director
Marco Caremi602002Executive Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 15,773,168 11,552,138 73.2% 0 0.0% 73.2%
Shareholders
NameEquities%
Investor AB 1,772,817 11.2%
Gefim SpA 1,311,957 8.32%
Aviva Plc 1,097,054 6.96%
JPMorgan Asset Management (UK) Ltd. 358,613 2.27%
UBS AG (Investment Management) 283,732 1.80%
Union Investment Privatfonds GmbH 149,140 0.95%
Polar Capital LLP 127,270 0.81%
Norges Bank Investment Management 121,793 0.77%
Aviva Investors Global Services Ltd. 121,616 0.77%
Credit Suisse AG 109,427 0.69%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
NEWRON PHARMACEUTICALS..19.35%366
AMGEN, INC.12.79%121 448
CELGENE CORPORATION7.87%97 137
GILEAD SCIENCES, INC.-5.74%88 227
REGENERON PHARMACEUTIC..4.52%40 701
ACTELION LTD24.40%29 848
VERTEX PHARMACEUTICALS..23.25%22 558
GENMAB A/S19.86%12 271
TESARO INC16.55%8 405
EXELIXIS, INC.43.33%6 216
HUALAN BIOLOGICAL ENGI..--.--%4 903
TONGHUA DONGBAO PHARMA..-2.46%4 420
KITE PHARMA INC74.53%4 291
BLUEBIRD BIO INC52.43%3 841
NEUROCRINE BIOSCIENCES..9.43%3 689
BIOCON LTD20.55%3 479
CLOVIS ONCOLOGY INC53.78%3 048
ULTRAGENYX PHARMACEUTI..-0.47%2 920
INTERCEPT PHARMACEUTIC..7.84%2 910
PEPTIDREAM INC-13.16%2 734
CHINA BIOLOGIC PRODUCT..-7.52%2 703
Sector Bio Therapeutic Drugs
Newron Pharmaceuticals SpA : Connections
Italian Angels For Biotech
Early Clinical Development Consulting Ltd.
White City Consulting ApS
Constantia Flexibles Group GmbH
Azanta A/S
Karolinska Development AB (Private Equity)
Oxford Gene Technology IP Ltd.
PJL Consulting
DFC Langlois
Wellington Partners GmbH
European School of Management & Technology GmbH
Assobiotec
Constantia Flexibles AG
NOXXON Pharma AG
MipSalus ApS
EryDel SpA
Orphazyme ApS
Universitätsklinikum Würzburg
CMC Contrast AB
The European Association for Bioindustries
Company contact information
Newron Pharmaceuticals SpA
via Ludovico Ariosto 21
Bresso, Milan 20091

Phone : +39.02.610.3461
Fax : +39.02.610.34654
Web : www.newron.com
© 2017 People , Fundamentals and Ownership